- Home
- SOAR vs XAIR Comparison
SOAR vs XAIR Comparison
Compare SOAR & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOAR
- XAIR
- Stock Information
- Founded
- SOAR 2021
- XAIR 2011
- Country
- SOAR United States
- XAIR United States
- Employees
- SOAR N/A
- XAIR N/A
- Industry
- SOAR Blank Checks
- XAIR Medical/Dental Instruments
- Sector
- SOAR Finance
- XAIR Health Care
- Exchange
- SOAR Nasdaq
- XAIR Nasdaq
- Market Cap
- SOAR 15.7M
- XAIR 17.0M
- IPO Year
- SOAR N/A
- XAIR N/A
- Fundamental
- Price
- SOAR $1.71
- XAIR $2.05
- Analyst Decision
- SOAR
- XAIR Strong Buy
- Analyst Count
- SOAR 0
- XAIR 1
- Target Price
- SOAR N/A
- XAIR $11.00
- AVG Volume (30 Days)
- SOAR 2.5M
- XAIR 245.7K
- Earning Date
- SOAR 11-17-2025
- XAIR 11-10-2025
- Dividend Yield
- SOAR N/A
- XAIR N/A
- EPS Growth
- SOAR N/A
- XAIR N/A
- EPS
- SOAR N/A
- XAIR N/A
- Revenue
- SOAR $96,397,000.00
- XAIR $4,782,000.00
- Revenue This Year
- SOAR N/A
- XAIR $261.11
- Revenue Next Year
- SOAR N/A
- XAIR $151.82
- P/E Ratio
- SOAR N/A
- XAIR N/A
- Revenue Growth
- SOAR 309.80
- XAIR 168.20
- 52 Week Low
- SOAR $1.14
- XAIR $1.81
- 52 Week High
- SOAR $19.06
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- SOAR 41.42
- XAIR 38.97
- Support Level
- SOAR $1.95
- XAIR $1.82
- Resistance Level
- SOAR $2.28
- XAIR $2.20
- Average True Range (ATR)
- SOAR 0.51
- XAIR 0.18
- MACD
- SOAR -0.14
- XAIR -0.05
- Stochastic Oscillator
- SOAR 1.49
- XAIR 24.73
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.